Darrell H. Tan, Ph.D. - Publications

Affiliations: 
2012 Health Policy, Management and Evaluation University of Toronto, Toronto, ON, Canada 
Area:
Medicine and Surgery, Epidemiology, Virology Biology

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Halani S, Tan D, Andany N. Long-acting injectable antiretroviral therapy for HIV-1 infection in adults. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 196: E341-E342. PMID 38499310 DOI: 10.1503/cmaj.231498  0.433
2023 Clifford Rashotte M, Yoong D, Naccarato M, Pico Espinosa OJ, Fisher K, Bogoch II, Tan DH. Appropriate usage of post-exposure prophylaxis-in-pocket for HIV prevention by individuals with low-frequency exposures. International Journal of Std & Aids. 9564624231215151. PMID 37963270 DOI: 10.1177/09564624231215151  0.453
2023 McClymont E, Tan DH, Bondy S, Albert A, Coutlée F, Lee M, Walmsley S, Ogilvie G, Money D. HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV. International Journal of Std & Aids. 9564624231154298. PMID 36702811 DOI: 10.1177/09564624231154298  0.496
2022 Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, Palich R, Nori A, Reeves I, Habibi MS, Apea V, Boesecke C, Vandekerckhove L, Yakubovsky M, Sendagorta E, ... ... Tan D, et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. The New England Journal of Medicine. PMID 35866746 DOI: 10.1056/NEJMoa2207323  0.453
2022 Wobeser WL, McBane JE, Balfour L, Conway B, Gill MJ, Huff H, Kilby DLP, Fergusson DA, Mallick R, Mills EJ, Muldoon KA, Rachlis A, Ralph ED, Rosenes R, Singer J, ... ... Tan D, et al. A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection. Plos One. 17: e0270590. PMID 35834528 DOI: 10.1371/journal.pone.0270590  0.614
2022 Christensen BL, Tan DH. An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV. Expert Opinion On Pharmacotherapy. 23: 439-446. PMID 35073817 DOI: 10.1080/14656566.2022.2029409  0.454
2021 Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, et al. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. Bmj Open. 11: e054208. PMID 34916326 DOI: 10.1136/bmjopen-2021-054208  0.587
2021 Suri S, Yoong D, Short D, Tan DH, Naccarato M, Crane HM, Musten A, Fredericksen RJ, Lober WB, Gough K. Feasibility of implementing a same-day electronic screening tool for clinical assessment to measure patient-reported outcomes for eliciting actionable information on adherence to HIV medication and related factors in a busy Canadian urban HIV clinic. International Journal of Std & Aids. 9564624211032796. PMID 34293990 DOI: 10.1177/09564624211032796  0.392
2021 MacKinnon KR, Grewal R, Tan DH, Rousseau R, Maxwell J, Walmsley S, MacPherson PA, Rachlis A, Andany N, Mishra S, Allen VG, Burchell AN. Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trial. Bmc Health Services Research. 21: 625. PMID 34193138 DOI: 10.1186/s12913-021-06602-1  0.631
2021 Hughes JM, Tan DH, Anderson P, Bodhinayake J, MacPherson PA. Infection with antiretroviral-susceptible HIV in an individual adherent to pre-exposure prophylaxis: strategies for treatment initiation. International Journal of Std & Aids. 956462420971125. PMID 33663292 DOI: 10.1177/0956462420971125  0.463
2021 Sinno J, Doria N, Cochkanoff N, Numer M, Neyedli H, Tan D. Attitudes and Practices of a Sample of Nova Scotian Physicians for the Implementation of HIV Pre-Exposure Prophylaxis. Hiv/Aids (Auckland, N.Z.). 13: 157-170. PMID 33574712 DOI: 10.2147/HIV.S287201  0.422
2020 Baranek B, Wang S, Cheung AM, Mishra S, Tan DH. The effect of tenofovir disoproxil fumarate on bone mineral density: a systematic review and meta-analysis. Antiviral Therapy. PMID 32077867 DOI: 10.3851/Imp3346  0.307
2019 Walmsley B, Gallant D, Naccarato M, Hull M, Smith A, Tan DH. The PrEP You Want: A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis Medications. Journal of Medical Internet Research. 21: e12076. PMID 31333200 DOI: 10.2196/12076  0.434
2019 Burchell AN, Lisk R, Yeung A, Rana J, Bacon J, Brunetta J, Gilbert M, Gesink D, Grewal R, Guiang CB, Kwag M, Logie CH, Mitterni L, Shahin R, Tan DH. Community-Directed Bacterial Sexually Transmitted Infection Testing Interventions Among Men Who Have Sex With Men: Protocol for an E-Delphi Study in Toronto, Canada. Jmir Research Protocols. 8: e13801. PMID 31274111 DOI: 10.2196/13801  0.444
2019 Grewal R, Allen VG, Bayoumi AM, Gardner SL, Kaul R, Mazzulli T, Moravan V, O'neill T, Raboud J, Rourke SB, Tan DH, Burchell AN. Syphilis co-infection is not associated with an increased risk of virologic failure among HIV-positive men who have sex with men on antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30730358 DOI: 10.1097/Qai.0000000000001962  0.47
2019 Grewal R, Yeung A, Brisson M, Grennan T, Pokomandy AD, Cox J, Lambert G, Moore DM, Coutlee F, Deeks S, Gardner S, Griffiths D, Isaranuwatchai W, Jollimore J, Murray J, ... ... Tan D, et al. P842 Healthcare engagement and HPV vaccination among gay, bisexual, and other men who have sex with men (gbMSM): a CIRN study Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.887  0.336
2019 Grewal R, Yeung A, Brisson M, Grennan T, Pokomandy AD, Cox J, Lambert G, Moore D, Coutlée F, Deeks S, Gardner S, Griffiths D, Isaranuwatchai W, Jollimore J, Murray J, ... ... Tan D, et al. P841 Barriers to HPV vaccination among gay, bisexual, and other men who have sex with men (gbMSM) in canada: a CIRN study Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.886  0.304
2019 Grennan T, Macpherson P, Burchell A, Claudio M, Edward J, Gillis J, Grace D, Nath R, Rosenes R, Tan D, Salit I. P840 The HPV screening and vaccine evaluation (HPV-SAVE) study in men living with HIV: early pathologic and acceptability outcomes Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.885  0.399
2019 Mcclymont E, Coutlée F, Lee M, Albert A, Walmsley S, Lipsky N, Ogilvie G, Tan D, Money D. P833 HSV-2 serostatus and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.878  0.534
2019 Wang L, Moqueet N, Lambert G, Grace D, Rodrigues R, Cox J, Lachowsky NJ, Noor S, Armstrong H, Tan D, Burchell A, Ma H, Knight J, Baral S, Hart T, et al. P512 Quantifying sexual mixing by HIV status and pre-exposure prophylaxis (PrEP) use among men who have sex (MSM) with men Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.592  0.548
2019 Armstrong H, Pan S, Barath J, Olarewaju G, Rodrigues R, Messier-Peet M, Apelian H, Hull M, Tan D, Lachowsky NJ, Jollimore J, Hart T, Grace D, Lambert G, Cox J, et al. P503 Trends in awareness and use of PrEP among HIV-negative men who have sex with men in vancouver, toronto, and montreal Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.583  0.454
2019 Guiang C, Burchell A, Rana J, Shahin R, Brunetta J, Mitterni L, Tan D, Bacon J, Gilbert M, Gesink D, Grewal R, Logie C, Yeung A, Lisk R. P087 Providers’ views on barriers and facilitators of bacterial STI testing among gbMSM living with or at risk for HIV Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.282  0.322
2019 Burchell A, Tan D, Grewal R, Walmsley S, Rachlis A, Macpherson P, Mishra S, Gardner S, Andany N, Rousseau R, Maxwell J, Thorpe K, Allen V. O18.4 Evaluation of routinized syphilis screening with HIV viral loads among men living with HIV Sexually Transmitted Infections. 95. DOI: 10.1136/Sextrans-2019-Sti.208  0.615
2018 Wang S, Kortenaar JL, Hull MW, Arbess G, Owen JR, Tan DH. Feasibility of vitamin D supplementation interventions to mitigate HIV pre-exposure prophylaxis-related bone mineral density loss: a cross-sectional survey. Patient Preference and Adherence. 12: 2197-2204. PMID 30410315 DOI: 10.2147/Ppa.S178403  0.391
2018 Singh AE, Tan D, Hull M, Bogoch II, MacPherson P, Tremblay C, Shafran S. Canadian guidelines on HIV pre-exposure prophylaxis (PrEP) and non-occupational post-exposure prophylaxis (nPEP): Discussion beyond the guidelines and commentary on the role of infectious diseases specialists Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 3: 165-177. DOI: 10.3138/JAMMI.2018-0024  0.327
2018 Dashwood T, Tan DH. PrEParing for the unexpected: mechanisms and management of HIV pre-exposure prophylaxis failure Future Virology. 13: 747-759. DOI: 10.2217/FVL-2018-0084  0.362
2017 Sivarajah V, Venus K, Yudin MH, Murphy KE, Morrison SA, Tan DH. Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review. Sexually Transmitted Infections. PMID 28600331 DOI: 10.1136/Sextrans-2016-052921  0.553
2017 Knox DC, Anderson PL, Harrigan PR, Tan DH. Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis. The New England Journal of Medicine. 376: 501-502. PMID 28146652 DOI: 10.1056/NEJMc1611639  0.433
2017 Grennan T, Smieja M, Chernesky M, Nath R, Jang D, Schnubb A, Tan DH. P2.45 High burden of persistent oncogenic hpv infection in high-risk, hiv-negative men who have sex with men using a novel hpv e6/e7 mrna assay Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.221  0.48
2017 Grewal R, Allen V, Bayoumi AM, Gardner SL, Kaul R, Mazzulli T, Mcgee F, Moravan V, O’neill T, Raboud J, Rourke SB, Tan DH, Burchell AN. P2.36 Sexually transmitted co-infections and the effect of drug use on risk of virologic failure among hiv-positive men on antiretroviral therapy Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.212  0.439
2017 Kortenaar J, Cheung A, Mewa S, Waugh E, Rubin L, Tan D. Exploring Strategies for Attenuating Changes in Bone Mineral Density in MSM on TDF/FTC HIV Pre-exposure Prophylaxis Open Forum Infectious Diseases. 4: S220-S220. DOI: 10.1093/Ofid/Ofx163.452  0.444
2016 Tan DH, Raboud J, Szadkowski L, Szabo E, Hu H, Wong Q, Cheung AM, Walmsley SL. Novel imaging modalities for the comparison of bone microarchitecture among HIV+ patients with and without fractures: a pilot study. Hiv Clinical Trials. 1-11. PMID 27951753 DOI: 10.1080/15284336.2016.1266074  0.559
2016 MacFadden DR, Tan DH, Mishra S. Optimizing HIV pre-exposure prophylaxis implementation among men who have sex with men in a large urban centre: a dynamic modelling study. Journal of the International Aids Society. 19: 20791. PMID 27665722 DOI: 10.7448/Ias.19.1.20791  0.479
2016 Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, Tan DH. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. Journal of the International Aids Society. 19: 20777. PMID 27265490 DOI: 10.7448/Ias.19.1.20777  0.524
2016 Grewal R, Allen VG, Gardner S, Moravan V, Tan DH, Raboud J, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Rourke SB, Burchell AN. Serosorting and recreational drug use are risk factors for diagnosis of genital infection with chlamydia and gonorrhoea among HIV-positive men who have sex with men: results from a clinical cohort in Ontario, Canada. Sexually Transmitted Infections. PMID 27154185 DOI: 10.1136/Sextrans-2015-052500  0.432
2016 Burchell AN, Allen VG, Grewal R, MacPherson PA, Rachlis A, Walmsley S, Mishra S, Gardner SL, Raboud J, Cooper C, Gough K, Rourke SB, Rousseau R, Salit I, Tan DH. Enhanced syphilis screening among HIV-positive men (ESSAHM): a study protocol for a clinic-randomized trial with stepped wedge design. Implementation Science : Is. 11: 8. PMID 26772390 DOI: 10.1186/S13012-016-0371-0  0.611
2015 Tan DH, Szadkowski L, Raboud J, Yi TJ, Shannon B, Kaul R, Liles WC, Walmsley S. Effect of Intercurrent Infections and Vaccinations on Immune and Inflammatory Biomarkers Among Human Immunodeficiency Virus-Infected Adults on Suppressive Antiretroviral Therapy. Open Forum Infectious Diseases. 2: ofv036. PMID 26380337 DOI: 10.1093/Ofid/Ofv036  0.58
2015 Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DH, Grewal R, Raboud J, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Rourke SB. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. Bmc Infectious Diseases. 15: 356. PMID 26289937 DOI: 10.1186/S12879-015-1098-2  0.464
2015 Yoong D, Naccarato M, Sharma M, Wilton J, Senn H, Tan DH. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis. International Journal of Std & Aids. PMID 26025254 DOI: 10.1177/0956462415589896  0.482
2015 Wilton J, Senn H, Sharma M, Tan DH. Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review. Hiv/Aids (Auckland, N.Z.). 7: 125-36. PMID 25987851 DOI: 10.2147/Hiv.S50025  0.53
2015 Tan DH, Raboud JM, Szadkowski L, Yi TJ, Shannon B, Kaul R, Liles WC, Walmsley SL. Herpes simplex virus type 2 serostatus is not associated with inflammatory or metabolic markers in antiretroviral therapy-treated HIV. Aids Research and Human Retroviruses. 31: 276-81. PMID 25399537 DOI: 10.1089/Aid.2014.0183  0.536
2015 Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DHS, Grewal R, Raboud J, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Rourke SB, Gardner S, Rueda S, Bayoumi A, ... ... Tan D, et al. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada Bmc Infectious Diseases. 15. DOI: 10.1186/s12879-015-1098-2  0.425
2014 Klein MB, Young J, Dunn D, Ledergerber B, Sabin C, Cozzi-Lepri A, Dabis F, Harrigan R, Tan DH, Walmsley S, Gill J, Cooper C, Scherrer AU, Mocroft A, Hogg RS, et al. The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study. Cmaj Open. 2: E318-29. PMID 25485259 DOI: 10.9778/cmajo.20140017  0.616
2014 Taras J, Arbess G, Owen J, Guiang CB, Tan DH. Acceptability of bone antiresorptive therapy among HIV-infected adults at different stages of antiretroviral therapy. Patient Preference and Adherence. 8: 1311-6. PMID 25284989 DOI: 10.2147/PPA.S67090  0.371
2014 Sharma M, Wilton J, Senn H, Fowler S, Tan DH. Preparing for PrEP: perceptions and readiness of canadian physicians for the implementation of HIV pre-exposure prophylaxis. Plos One. 9: e105283. PMID 25133648 DOI: 10.1371/journal.pone.0105283  0.34
2014 Sharma M, Tan DH. HIV pre-exposure prophylaxis. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 186: E588. PMID 25096663 DOI: 10.1503/cmaj.140127  0.437
2014 Tran JM, Li A, Owino M, English K, Mascarenhas L, Tan DH. HIV testing during the Canadian immigration medical examination: a national survey of designated medical practitioners. Aids Care. 26: 1550-4. PMID 25029636 DOI: 10.1080/09540121.2014.936811  0.452
2014 Tan DH, Raboud JM, Kaul R, Walmsley SL. Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study. Bmj Open. 4: e004210. PMID 24464523 DOI: 10.1136/Bmjopen-2013-004210  0.632
2014 Macfadden D, Tan D, Mishra S. 1525Optimizing HIV Pre-Exposure Prophylaxis Implementation among Men Who Have Sex with Men in Toronto: A Dynamic Modelling Study Open Forum Infectious Diseases. 1: S404-S405. DOI: 10.1093/Ofid/Ofu052.1071  0.453
2013 Tan DH, Murphy K, Shah P, Walmsley SL. Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies. Bmc Infectious Diseases. 13: 502. PMID 24164861 DOI: 10.1186/1471-2334-13-502  0.661
2013 Chan AC, Gough K, Yoong D, Dimeo M, Tan DH. Non-occupational post-exposure prophylaxis for HIV at St Michael's Hospital, Toronto: a retrospective review of patient eligibility and clinical outcomes. International Journal of Std & Aids. 24: 393-7. PMID 23970708 DOI: 10.1177/0956462412472826  0.412
2013 Yi TJ, Walmsley S, Szadkowski L, Raboud J, Rajwans N, Shannon B, Kumar S, Kain KC, Kaul R, Tan DH. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1331-8. PMID 23946220 DOI: 10.1093/Cid/Cit539  0.588
2013 Tan DH, Walmsley SL. Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit. Critical Care Clinics. 29: 603-20. PMID 23830655 DOI: 10.1016/j.ccc.2013.03.010  0.605
2013 Senn H, Wilton J, Sharma M, Fowler S, Tan DH. Knowledge of and opinions on HIV preexposure prophylaxis among front-line service providers at Canadian AIDS service organizations. Aids Research and Human Retroviruses. 29: 1183-9. PMID 23731254 DOI: 10.1089/AID.2013.0090  0.398
2013 Burchell AN, Allen VG, Moravan V, Gardner S, Raboud J, Tan DH, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Millson P, Remis RS, Rourke SB. Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000-2009. Bmc Infectious Diseases. 13: 246. PMID 23710699 DOI: 10.1186/1471-2334-13-246  0.555
2013 Tan DH, Raboud JM, Kaul R, Brunetta J, Kaushic C, Kovacs C, Lee E, Luetkehoelter J, Rachlis A, Smaill F, Smieja M, Walmsley SL. Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 448-57. PMID 23572481 DOI: 10.1093/Cid/Cit208  0.635
2013 Burchell AN, Allen V, Moravan V, Gardner S, Raboud J, Tan D, Bayoumi A, Kaul R, Remis RS, Rourke SB. P3.211 Extremely High Risk of Syphilis Co-Infection and Re-Diagnosis Among Men Who Have Sex with Men Living with HIV in Ontario, Canada Sexually Transmitted Infections. 89: A214.2-A214. DOI: 10.1136/Sextrans-2013-051184.0668  0.477
2012 Tan D. Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females. International Journal of Women's Health. 4: 341-350. PMID 22927765 DOI: 10.2147/Ijwh.S27601  0.489
2011 Leonardi M, Lee E, Tan DH. Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada. International Journal of Std & Aids. 22: 738-41. PMID 22174057 DOI: 10.1258/ijsa.2011.011057  0.437
2011 Tan DH, Chan K, Raboud J, Cooper C, Montaner JS, Walmsley S, Hogg RS, Klein MB, Machouf N, Rourke SB, Tsoukas C, Loutfy MR. Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 38-46. PMID 21709570 DOI: 10.1097/Qai.0B013E3182282Cfc  0.571
2011 Tan DH, Kaul R, Raboud JM, Walmsley SL. No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults. Aids (London, England). 25: 207-10. PMID 21150556 DOI: 10.1097/Qad.0B013E328341Ddf7  0.569
2010 Tan DH, Raboud JM, Kaul R, Grinsztejn B, Cahn P, Walmsley SL. Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial. Trials. 11: 113. PMID 21106086 DOI: 10.1186/1745-6215-11-113  0.63
2010 Tan DH, Walmsley SL. Response to Stegmann s, et Al. [J. Clin. Virol. 47 (1) (2010) 79-81]. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 47: 297-8. PMID 20079687 DOI: 10.1016/j.jcv.2009.12.016  0.325
2009 Tan DH, Kaul R, Walsmley S. Left out but not forgotten: Should closer attention be paid to coinfection with herpes simplex virus type 1 and HIV? The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 20: e1-7. PMID 20190881 DOI: 10.1155/2009/965263  0.53
2008 Burgoyne RW, Tan DH. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act. The Journal of Antimicrobial Chemotherapy. 61: 469-73. PMID 18174196 DOI: 10.1093/jac/dkm499  0.391
2007 Tan D, Walmsley S. Lopinavir plus ritonavir: A novel protease inhibitor combination for HIV infections Expert Review of Anti-Infective Therapy. 5: 13-28. PMID 17266450 DOI: 10.1586/14787210.5.1.13  0.637
2006 Tan D, Walmsley S, Shen S, Raboud J. Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors. Hiv Clinical Trials. 7: 107-15. PMID 16880167 DOI: 10.1310/95Ve-A6Kj-Wrq0-1F8Y  0.523
2003 Tan DH, Upshur RE, Ford N. Global plagues and the Global Fund: Challenges in the fight against HIV, TB and malaria. Bmc International Health and Human Rights. 3: 2. PMID 12667262 DOI: 10.1186/1472-698X-3-2  0.394
Show low-probability matches.